Meta, the tech behemoth behind Facebook and Instagram, is once again in the hot seat, this time for turning a blind eye to a rather insidious issue. Despite federal investigations and their own policies against such practices, the company is still running advertisements that peddle illicit drugs, some laced with the deadly opioid fentanyl. The Wall Street Journal (WSJ) has shed light on this alarming trend, showing that Meta’s ad marketplace continued to profit from these illegal ads even after federal prosecutors in Virginia launched an investigation into the matter.
The ads in question are particularly crafty, often skirting Meta’s automated censors by using images instead of text descriptions. For instance, one ad featured the letters “DMT” spelled out in a powdered form of the hallucinogenic drug, N,N-Dimethyltryptamine. Clicking these ads typically leads users to third-party websites or, more commonly, dealer chat feeds on Telegram, a less-regulated messaging app not owned by Meta. This loophole allows dealers to bypass Meta’s AI censoring systems, making it alarmingly easy for users to access dangerous substances.
The WSJ has been instrumental in bringing these ads to Meta’s attention. Despite Meta’s claims of proactive content detection and enforcement, it’s clear that many ads for cocaine and prescription opioids slipped through the cracks. The Tech Transparency Project watchdog group reported that from March to June alone, over 450 such ads were running on Meta’s Ad Library. Once the WSJ alerted Meta to the existence of these ads, they were promptly taken down, showcasing the typical reactive approach of tech giants when confronted with media scrutiny.
Adding a tragic dimension to this issue, these digital drug deals have dire real-world consequences. The WSJ highlighted a particularly heartbreaking case involving a teenager whose autopsy revealed a fatal amount of fentanyl in his system. His mother, Mikayla Brown, is convinced that the drugs he bought off Instagram were laced with the deadly opioid. Even more horrifying, the accounts the teen had interacted with remained active for months following his death, only being deactivated once the WSJ brought them to Meta’s attention.
Meta’s spokesperson emphasized that their systems are designed to actively detect and remove violating content, rejecting hundreds of thousands of ads for drug policy violations. They also assured that the company continues to invest resources to improve enforcement. However, the persistence of these ads and their associated fatalities calls into question the effectiveness of these measures. The fact that these advertisements not only exist but also generate revenue for Meta is deeply troubling.
The crux of the issue is not just about policy enforcement but also about the ethical responsibilities of tech giants in safeguarding their platforms. With lives at stake, Meta’s reactive approach is insufficient. Robust, proactive measures are imperative to prevent such tragic outcomes and ensure that digital spaces do not become marketplaces for deadly substances. The current state of affairs mandates a reassessment of Meta’s advertising oversight mechanisms, emphasizing the need for stringent and effective controls to protect users from the perils lurking within their digital ecosystems.
By
